Researchers at UCLA have identified a new stem cell that participates in the repair of the large airways of the lungs, which play a vital role in protecting the body from infectious agents and toxins in the environment.
The airways protect the body by producing and clearing mucus from the airways. The mucus is largely produced by specialized mucus glands in the airway and the mechanisms of normal and excessive mucus production are not well understood. However, this newly discovered lung stem cell for the mucus glands will likely yield new insights into this critical process.
The study, by scientists with the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA, represents the first time anyone has found the cell of origin for the many types of cells that make up the mucus glands and that can also repair the surface epithelium. The finding, the study states, is of "major importance to the field of lung regeneration."
"We're very excited that we found this population of cells because it will allow us to study mechanisms of diseases of the upper airway," said Dr. Brigitte Gomperts, an assistant professor of pediatrics and hematology/oncology and senior author of the study. "For example, there currently are no treatments for excess mucus production, which we see in cystic fibrosis, asthma and chronic obstructive pulmonary disease (COPD). But if we can understand the mechanisms of how these stem cells repair the mucus glands, then we may be able to find a way to put the brakes on the system and prevent mucus over production."
The study appears in the June 27, 2011 issue of the peer-reviewed journal Stem Cells.
Ahmed Hegab, a postdoctoral scholar in Gomperts lab and first author on the study, named the newly discovered cells sub-mucosal gland duct stem cells, because they are found in the ducts where the mucus is first secreted. Hegab and Gomperts had been looking for the lung stem cells for years, and created a model of repair of the airways in order to identify the location of the stem cells.
Once Gomperts and her team proved that the lung stem cells existed and found where they "lived," they set out to isolate them and confirm that they could self-renew, or grow more of themselves, and differentiate, turn into the cells that make up the mucus glands and surface epithelium. They created model systems in which these isolated stem cells did, in fact, make mucus glands with all the types of cells required to make mucus and repair the surface barrier of the large airways.
"Our ability to identify the stem cells and their regenerative ability has implications for the possible identification of novel therapeutic targets for airway diseases and potential cell-based therapies in the future," the study states.
The stem cells also may play a role in tumor initiation in lung cancer when the repair goes awry, although further study is needed to confirm this, said Gomperts, who is also a member of UCLA's Jonsson Comprehensive Cancer Center.
This study was funded by the California Institute of Regenerative Medicine, American Thoracic Society/COPD Foundation, the Concern Foundation, UCLA's Jonsson Comprehensive Cancer Center's Thoracic Oncology Program and Specialized Program of Research Excellence in lung cancer, the University of California Cancer Research Coordinating Committee and the Gwynne Hazen Cherry Memorial Laboratories.
The stem cell center was launched in 2005 with a UCLA commitment of $20 million over five years. A $20 million gift from the Eli and Edythe Broad Foundation in 2007 resulted in the renaming of the center. With more than 200 members, the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research is committed to a multi-disciplinary, integrated collaboration of scientific, academic and medical disciplines for the purpose of understanding adult and human embryonic stem cells. The center supports innovation, excellence and the highest ethical standards focused on stem cell research with the intent of facilitating basic scientific inquiry directed towards future clinical applications to treat disease. The center is a collaboration of the David Geffen School of Medicine, UCLA's Jonsson Cancer Center, the Henry Samueli School of Engineering and Applied Science and the UCLA College of Letters and Science. To learn more about the center, visit our web site at http://www.